Bender Robert & Associates
- SEC CIK
- 0000894300
- Latest filing
- Jul 30, 2026
PLSE holding history
Pulse Biosciences, Inc. in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLSE overviewAll 13F holders of PLSEFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −12,190−100.0% | Sold out | Holders |
| Q1 2026 | 12,190 | $263.2K | 0.1% | +12,190 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −11,590−100.0% | Sold out | Holders |
| Q3 2025 | 11,590 | $205.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 11,590 | $174.9K | <0.1% | +11,590 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −11,590−100.0% | Sold out | Holders |
| Q4 2024 | 11,590 | $201.8K | <0.1% | +11,590 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −10,325−100.0% | Sold out | Holders |
| Q4 2023 | 10,325 | $126.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,325 | $41.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,325 | $74.2K | <0.1% | +10,325 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −8,825−100.0% | Sold out | Holders |
| Q1 2021 | 8,825 | $209.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.